Medical device firm UltraGuide this month brought its UltraGuide 1000 ultrasound-guided interventional procedure tool to market. The Israeli firm developed the device for biopsies and treatments of abdominal organs and breast interventions, as well as
Medical device firm UltraGuide this month brought its UltraGuide 1000 ultrasound-guided interventional procedure tool to market. The Israeli firm developed the device for biopsies and treatments of abdominal organs and breast interventions, as well as cardiology, ob/gyn, and prenatal procedures. The device was cleared by the Food and Drug Administration in February of last year and is priced at about $45,000 (SCAN 6/24/98).
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.